Accelerated atherosclerosis in patients with SLE—mechanisms and management

Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis

(2011) W. Marder et al.   ANNALS OF THE RHEUMATIC DISEASES

Recent Advances on the Role of Cytokines in Atherosclerosis

(2011) Hafid Ait-Oufella et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Differential effects of regulatory T cells on the initiation and regression of atherosclerosis

(2011) A.C. Foks et al.   ATHEROSCLEROSIS

Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice

(2011) M. Mosca et al.   AUTOIMMUNITY REVIEWS

Macrophages in the Pathogenesis of Atherosclerosis

(2011) Kathryn J. Moore et al.   CELL

Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects

(2011) Ian Toma et al.   CELL AND TISSUE RESEARCH

Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis

(2011) Tin Kyaw et al.   CURRENT OPINION IN LIPIDOLOGY

Effector T-cell subsets in systemic lupus erythematosus

(2011) Min S. Shin et al.   CURRENT OPINION IN RHEUMATOLOGY

Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus

(2011) E. Villanueva et al.   JOURNAL OF IMMUNOLOGY

Mycophenolate Mofetil Decreases Atherosclerotic Lesion Size by Depression of Aortic T-Lymphocyte and Interleukin-17–Mediated Macrophage Accumulation

(2011) Sibylle von Vietinghoff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The immune system in atherosclerosis

(2011) Göran K Hansson et al.   NATURE IMMUNOLOGY

Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE

(2011) Deborah P. M. Symmons et al.   Nature Reviews Rheumatology

The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus

(2011) J Michelle Kahlenberg et al.   ARTHRITIS RESEARCH & THERAPY

Efeitos de autoanticorpos antilipoproteína lipase, antilipoproteína de baixa densidade e antilipoproteína de baixa densidade oxidada sobre o metabolismo lipídico e aterosclerose no lúpus eritematoso sistêmico

(2011) James Fesmire et al.   Revista Brasileira De Reumatologia

Lupus Atherosclerosis Prevention Study (LAPS)

(2010) M. A. Petri et al.   ANNALS OF THE RHEUMATIC DISEASES

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus

(2010) Sean G. O'Neill et al.   ARTHRITIS AND RHEUMATISM

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

(2010) Hyejung Jung et al.   ARTHRITIS AND RHEUMATISM

How does interferon-α insult the vasculature? Let me count the ways

(2010) Mariana J. Kaplan et al.   ARTHRITIS AND RHEUMATISM

Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: A novel link between interferon-α and atherosclerosis in lupus

(2010) Jia Li et al.   ARTHRITIS AND RHEUMATISM

Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis

(2010) Sander I. van Leuven et al.   ATHEROSCLEROSIS

B cell depletion reduces the development of atherosclerosis in mice

(2010) Hafid Ait-Oufella et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis

(2010) T. Kyaw et al.   JOURNAL OF IMMUNOLOGY

The Detrimental Effects of IFN-  on Vasculogenesis in Lupus Are Mediated by Repression of IL-1 Pathways: Potential Role in Atherogenesis and Renal Vascular Rarefaction

(2010) S. G. Thacker et al.   JOURNAL OF IMMUNOLOGY

A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs

(2010) M. F. Denny et al.   JOURNAL OF IMMUNOLOGY

Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis

(2010) Q. Huang et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis

(2010) Lee Ann Campbell et al.   MICROBES AND INFECTION

Long-term improvement of lipid profile in patients with refractory systemic lupus erythematosus treated with B-cell depletion therapy: a retrospective observational study

(2010) J. M. Pego-Reigosa et al.   RHEUMATOLOGY

Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis

(2010) Young Hee Rho et al.   ARTHRITIS CARE & RESEARCH

Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study

(2010) Jinoos Yazdany et al.   ARTHRITIS RESEARCH & THERAPY

Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis

(2010) Jennifer MP Woo et al.   ARTHRITIS RESEARCH & THERAPY

Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study

(2009) I. Rua-Figueroa et al.   ANNALS OF THE RHEUMATIC DISEASES

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

(2009) M. Mosca et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

(2009) M J L Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis

(2009) Christina Charles-Schoeman et al.   ARTHRITIS AND RHEUMATISM

Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus

(2009) Maureen McMahon et al.   ARTHRITIS AND RHEUMATISM

Premature atherosclerosis in pediatric systemic lupus erythematosus: Risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort

(2009) Laura E. Schanberg et al.   ARTHRITIS AND RHEUMATISM

Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus

(2009) Harmony R. Reynolds et al.   ATHEROSCLEROSIS

Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease

(2009) A. Recio-Mayoral et al.   EUROPEAN HEART JOURNAL

Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome

(2009) Marietta Charakida   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Metabolic Syndrome Is Associated with Increased Arterial Stiffness and Biomarkers of Subclinical Atherosclerosis in Patients with Systemic Lupus Erythematosus

(2009) J. M. SABIO et al.   JOURNAL OF RHEUMATOLOGY

Risk Factors for Clinical Coronary Heart Disease in Systemic Lupus Erythematosus: The Lupus and Atherosclerosis Evaluation of Risk (LASER) Study

(2009) S. HAQUE et al.   JOURNAL OF RHEUMATOLOGY

Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis

(2009) CP Chung et al.   LUPUS

Adipokines as novel biomarkers in paediatric systemic lupus erythematosus

(2009) M. Al et al.   RHEUMATOLOGY

Coronary Artery Calcification Compared With Carotid Intima-Media Thickness in the Prediction of Cardiovascular Disease IncidenceThe Multi-Ethnic Study of Atherosclerosis (MESA)

(2008) Aaron R. Folsom   ARCHIVES OF INTERNAL MEDICINE

Homocysteine or Renal Impairment

(2008) Kathleen Potter et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein A-I mimetic peptides

(2008) Brian J. Van Lenten et al.   Current Atherosclerosis Reports

Interferon gamma: A master regulator of atherosclerosis

(2008) James E. McLaren et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort

(2008) S. Duran-Barragan et al.   RHEUMATOLOGY

Antibodies to oxidized LDL/β2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism

(2008) V. Pengo et al.   THROMBOSIS RESEARCH